BlackRock Fund Advisors’s Dare Bioscience DARE Stock Holding History

BlackRock Fund Advisors’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$31K	Buy	369 +13	+4%	+$1.24K	﹤0.01%	3837
2016 Q3	$45K	Sell	356 -1	-0.3%	-$224	﹤0.01%	3807
2016 Q2	$91K	Sell	357 -7	-2%	-$2.24K	﹤0.01%	3694
2016 Q1	$118K	Sell	364 -29	-7%	-$8.18K	﹤0.01%	3625
2015 Q4	$132K	Buy	393 +13	+3%	+$5.39K	﹤0.01%	3666
2015 Q3	$167K	Buy	380 +75	+25%	+$37.7K	﹤0.01%	3549
2015 Q2	$169K	Buy	+305	New	+$209K	﹤0.01%	3586

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Fund Advisors's DARE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Dare Bioscience (DARE) stake by 3.7% in Q4 2016, buying an estimated $1.24K and bringing the position to 369 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

BlackRock Fund Advisors first reported a position in DARE in Q2 2015 and has held it in 7 quarters since. The position peaked at $169K in Q2 2015. 30 funds tracked by Wall St. Rank hold DARE as of Q4 2016.

BlackRock Fund Advisors held 369 shares of Dare Bioscience worth $31K as of Q4 2016.
BlackRock Fund Advisors bought 13 Dare Bioscience shares in Q4 2016, an estimated $1.24K.
Dare Bioscience made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3837 holding.
BlackRock Fund Advisors first reported a position in Dare Bioscience in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's Dare Bioscience position peaked at $169K in Q2 2015.
30 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.